Evidence map›Paper›PMID 41066105›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Platelets engage mast cells in a bilateral IL-33-driven feed-forward loop.

Airi Nishida, Jun Nagai, Madeline Hastings, Kendall Zaleski, Marie Sasaki, Omar Samir, Juying Lai, Sofia A Marshall, Hiroaki Hayashi, Sreyashi Majumdar and 4 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Developments in Mast Cell Research.The Journal of allergy and clinical immunology · 2026
    Review
  2. Review
  3. CD25 expression marks an activated mast cell population in human nasal polyposis.The Journal of allergy and clinical immunology · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Platelet-mast cell dialogue in innate immune response and inflammation.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Airi NishidaDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.ORCID 0009-0001-0028-5101
Jun NagaiDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.ORCID 0000-0003-4720-5065
Madeline HastingsDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.
Kendall ZaleskiDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.ORCID 0009-0002-0868-7575
Marie SasakiDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.
Omar SamirDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.ORCID 0000-0002-2022-5069
Juying LaiDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.ORCID 0000-0001-5900-7504
Sofia A MarshallDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.
Hiroaki HayashiDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.
Sreyashi MajumdarDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.ORCID 0000-0002-1555-3105
Kinan AlhallakDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.
Chunli FengDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.
Tao LiuDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.
Joshua A BoyceDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA 02115.ORCID 0000-0002-2401-2351

Funding

Therapeutic Control of Aspirin-Exacerbated Respiratory DiseaseU19AI095219 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Maria Gutierrez-Arcelus · 2011 to 2026
$29.1M
IMMUNOLOGIC BASIS OF RESISTANCE AND HYPERSENSITIVITYT32AI007306 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett, Joshua A Boyce · 1985 to 2026
$12.2M
Regulation of Pulmonary Prostaglandins by Leukotriene E4R01AI078908 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BOYCE, JOSHUA A · 2009 to 2025
$8.8M
Eicosanoid Networks in Aspirin HypersensitivityR01AI136041 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Joshua A Boyce · 2018 to 2026
$5.4M
CysLT and P2Y Receptors in Lung InflammationR37AI052353 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BOYCE, JOSHUA A · 2013 to 2022
$5.2M
Prostaglandin E2-Dependent Control of a Mast Cell IL-33/ST2 Pathway in AsthmaR01AI175149 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Joshua A Boyce · 2023 to 2026
$3.4M
Optimizing EP receptor subtype targeting for asthma therapyR01HL136209 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI BIRRELL, MARK A, BOYCE, JOSHUA A · 2017 to 2020
$2.2M
Nucleotide releasing profiles in allergic inflammatory diseasesR21AI156068 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI NAGAI, JUN · 2021 to 2022
$462k
American Lung Association (ALA) Catalyst AwardGoldberg Family Foundation (The Goldberg Family Foundation) Nurture Scientific CareersHHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL111113HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL117945HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL136209HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI078908HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI130109HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI136041HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI175149HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R21AI156068HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R37AI052353HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) T32AI007306HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U19AI095219
6 · The paper itself

Abstract

Platelets amplify type 2 inflammation (T2I) through incompletely understood mechanisms. Depletion of platelets markedly attenuated mast cell (MC) activation in a model of aspirin exacerbated respiratory disease (AERD) that depends on IL-33 and cysteinyl leukotrienes (cysLTs). We demonstrate an IL-33-driven feed-forward loop between platelets and MCs. IL-33 neutralization prevented increases in cysLTs and CXCL7, a platelet activation marker, in bronchoalveolar lavage (BAL) fluid from AERD-like mice in response to aspirin challenges. BAL fluid concentrations of PGD

Indexed as

Blood PlateletsInterleukin-33Mast CellsAnimalsAsthmaBronchoalveolar Lavage FluidCysteineFemaleHumansLeukotriene C4LeukotrienesMaleMiceMice, Inbred C57BLMice, KnockoutPlatelet ActivationCysteinecysteinyl-leukotrieneIl33 protein, mouseInterleukin-33Leukotriene C4LeukotrienesProstaglandin D2IL-33leukotrienesmast cellsnucleotidesplatelets

Identifiers

PMID41066105
PMCPMC12541455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.